Related Tags >> GlaxoSmithKline Drug Trials Phase III Eli Lilly

Isolagen News

Most Popular Isolagen Story

ALSO NOTED: Tacere gains Pfizer deal; InterMune reports positive hep C results; ArQule CEO resigns; and much more...

January 8, 2008 — 7:59am ET

> Tacere Therapeutics has inked a development deal with Pfizer for its preclinical hepatitis C drug. The deal is worth up to $145 million in potential milestones and Pfizer is paying an... Read more...

Isolagen Press Releases

PRESS RELEASE: Isolagen Modifies Ongoing Clinical Program For Acne Scars

Latest Headlines

ALSO NOTED: Analysts offer conflicting forecasts for Auxilium; test sheds light on cancer therapy; MAP touts new data; and much
March 24, 2008
C&L: Klemm named CEO of Predictive Biosciences
March 19, 2008
ALSO NOTED: Tacere gains Pfizer deal; InterMune reports positive hep C results; ArQule CEO resigns; and much more...
January 8, 2008
SPOTLIGHT: Isolagen modifies trial in response to FDA
November 28, 2007
C&L: Freytag tapped as new Aspreva CEO
July 11, 2007
Isolagen to shutter its UK subsidiary
November 7, 2006
DEALS: GSK, ChemoCentryx ink $1.5B pact
August 30, 2006
SPOTLIGHT: Isolagen buys Agera stake
August 17, 2006
C&L: Jones to retire from Digene
June 13, 2006
C&L: Phase III Medical taps Robin Smith as CEO
June 6, 2006
ALSO NOTED: Orion nixes Phase III; Xechem granted orphan status; Amgen to pay Mass General; and much more...
June 5, 2006
C&L: Susan Ciallella temporarily takes helm at Isolagen
October 4, 2005
ALSO NOTED: FDA investigates 5 neurological cases; DeLape resigns as Isolagen CEO; Tessera raises $8.5M; and much more...
October 2, 2005
SPOTLIGHT: Isolagen reports mixed Phase III data
July 31, 2005
C&L: Horobin takes over at U3 Pharma
July 12, 2005

Paid Research Reports